Skip to content
Medical Health Aged Care

Healthscope and Bupa’s renewed partnership helping modernise patient care

August 17, 2023 2 mins read

Improved patient experience and a focus on contemporary models of care underpins a renewed three-year partnership between Healthscope and Bupa.

 

As part of the renewed hospital contract, a Joint Steering Committee, to be comprised of clinicians and senior leaders from Bupa and Healthscope, will be established to help expand offerings for Bupa members on new models of care to improve the value of private health care, while also collaborating on new initiatives to introduce efficiencies into the overall system.

 

Patient and members’ hospital experience will help drive change with their feedback and insights shared with the committee to help ensure their clinical and non-clinical needs are understood and met.

 

Healthscope CEO Greg Horan said the renewed partnership with Bupa represented a step change that would help deliver outstanding patient care for Bupa members, underpinned by sustainable hospital funding and a reduced administrative and compliance burden.

 

“This is a truly collaborative partnership that recognises the rising costs facing private hospitals, and also sees both parties committed to delivering innovative new care options,” Mr Horan said.

 

“With sustainable funding embedded in the partnership, we will be able to jointly invest in enhancing overall experience for Bupa members during their health care journey in our hospitals.”

 

The agreement between Bupa and Healthscope, which is the only private hospital group to have hospitals in every state and territory in Australia, will help limit out of pocket costs for patients and members.

 

Bupa Health Insurance Managing Director Chris Carroll said the partnership with Healthscope acknowledged increased costs in healthcare and a commitment to innovative models of care which leads to care in the most appropriate setting with positive outcomes.

 

“Going to hospital can be a daunting and stressful time for people, so we’re thrilled our members can have peace of mind knowing they’ll be covered at Healthscope hospitals,” Mr Carroll said.

 

“Our partnership with Healthscope is a great example of hospitals and private health insurers working together to explore new initiatives while ensuring greater choice of care and keeping healthcare affordable.

 

“This agreement recognises the changing clinical needs of our members and being part of a contemporary health care system.”



For more information, please contact:


Aleks Devic                                                          
Senior External Communications Manager, Bupa                                        
Email: [email protected]   

Mob: 0412 868 933                                                            

 

Jim Cooper

Senior Manager Corporate Affairs, Healthscope

Email: [email protected]

Mob: 0438 588 619

 

 

About Bupa Asia Pacific

Bupa is an international healthcare group which has been committed to a purpose of helping people live longer, healthier, happier lives and making a better world for more than 70 years.

Bupa Asia Pacific operates in Australia, New Zealand and Hong Kong, supporting about 6.5 million customers through a broad range of health and care services including health insurance, aged care, dental, medical, optical and hearing services.

Employing more than 20,000 people in the region, we believe that we can make a real difference to the lives of customers through our values, purpose and the way that we deliver personalised care.

Since 2002, we have reinvested approximately $6 billion in the region, with the Bupa Foundation investing more than $34 million to support 130+ health and care projects.

 

About Healthscope

Healthscope is Australia’s only national private hospital provider, operating 38 hospitals across the country, and employing over 18,000 people. Healthscope offers world-class patient care, including medical and surgical services, mental health treatment and rehabilitation services.

 

 

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.